Results From the PARADIGM Phase 3 Head-to-Head Trial of Vectibix® (panitumumab) Versus Bevacizumab in Untreated RAS Wild-Type Metastatic Colorectal Cancer*
Largest Evaluation of Acquired Resistance to
Key takeaways:
Leapmotor plans to go public in Hong Kong, becoming the fourth Chinese electric vehicle startup to list on the exchange
The money-losing company is trying to shift gears from making mini EVs to more traditional sedans at the mid- to high-end of the market
By Ken Lo